Founder and Recurrent CDH1 Mutations in Families With Hereditary Diffuse Gastric Cancer
Pardeep Kaurah(University of British Columbia), David G. Huntsman(BC Cancer Agency), Bridget A. Fernandez(Memorial University of Newfoundland), Mary Connolly-Wilson(Health Sciences Centre), Robert M. Greenstein, Steven Gallinger(Ontario Institute for Cancer Research), Daniel G. Coit(Memorial Sloan Kettering Cancer Center), Sarah M. Nikkel(Children's Hospital of Eastern Ontario), Sam S. Yoon(Massachusetts General Hospital), Lori Van Manen(Queen's University), Alessandro De Luca(Casa Sollievo della Sofferenza), Gregory Y. Lauwers(University of South Florida), Scott M. Weissman, Marc Tischkowitz(University of Cambridge), Sonya Zaor(McGill University), Wendy McKinnon(University of Vermont), Yim Dwight, Jennifer Stroop, Marc S. Greenblatt(University of Vermont), Wendy S. Rubinstein(National Cancer Institute), Carla Oliveíra(Universidade do Porto), Gianpaolo Suriano(Universidade do Porto), Niki Boyd(University of British Columbia), Sylviane Olschwang(Inserm), Janine Senz(University of British Columbia), Antonio Pizzuti(Casa Sollievo della Sofferenza), Daniel C. Chung(Icahn School of Medicine at Mount Sinai), Paul D.P. Pharoah(Cedars-Sinai Medical Center), Carlos Vaccaro(Hospital Italiano de Buenos Aires), Jane Green(Memorial University of Newfoundland), Nicki Chun(Stanford University), Andrée MacMillan(Health Sciences Centre), Debrah Wirtzfeld(Memorial University of Newfoundland), María Ana Redal(Hospital Italiano de Buenos Aires), Cathy Gilpin(Children's Hospital of Eastern Ontario), Henry T. Lynch(Creighton University), Benoît Panzini(Université de Montréal), James M. Ford(Stanford University), Daniel Fontaine(Memorial University of Newfoundland), Courtney Sebold(The University of Texas at San Antonio Health Science Center)
Cited by 455
Related Papers
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k